Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v4-EN
Language French English
Date Updated 2017-10-03 2017-10-03
Drug Identification Number 02285614 02285614
Brand name ALVESCO ALVESCO
Common or Proper name ciclesonide ciclesonide
Company Name COVIS PHARMA GMBH COVIS PHARMA GMBH
Ingredients CICLESONIDE CICLESONIDE
Strength(s) 200MCG 200MCG
Dosage form(s) AEROSOL, METERED DOSE AEROSOL, METERED DOSE
Route of administration INHALATION INHALATION
Packaging size 120 doses 120 doses
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-10-06 2017-10-06
Actual start date
Estimated end date 2017-10-20 2017-10-20
Actual end date 2017-10-02 2017-10-02
Shortage status Avoided shortage Avoided shortage
Tier 3 Status No No
Company comments
Health Canada comments